Marketing-authorisation holder · United States
Teva Branded Pharm
38 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United States
38 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIGALL150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 300MG · Capsule | Ursodeoxycholic acid | United States | Marketed | 1987 |
| AUSTEDO12mg | 6mg | 9mg · Tablet | Deutetrabenazine | United States | Marketed | 2017 |
| CONDYLOX0.5% · Solution | Podofilox | United States | Not marketed | 1990 |
| DIAMOX125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Acetazolamide | United States | Not marketed | 1953 |
| DIAMOX500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended release | Acetazolamide | United States | Not marketed | 1962 |
| EMLA2.5%; 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Cream | Lidocaine, Prilocaine | United States | Not marketed | 1992 |
| LOESTRIN 21 1/200.02MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1976 |
| LOESTRIN 21 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1976 |
| LOESTRIN 24 FE0.02MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 2006 |
| LOESTRIN FE 1/200.02MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1973 |
| LOESTRIN FE 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1973 |
| LOSEASONIQUE0.02mg,0.1mg; 0.01mg,n/a · Tablet | Ethinyl estradiol, Levonorgestrel, N/a | United States | Marketed | 2008 |
| LOXITANE10MG BASE **Federal Register determination that product was discontinued or withdrawn for s or e reasons** | 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Loxapine | United States | Not marketed | 1975 |
| LOXITANE10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE * · Capsule | Loxapine | United States | Not marketed | 1975 |
| LOXITANE C25mg base/ml · Concentrate | Loxapine | United States | Not marketed | 1976 |
| MICROZIDE12.5mg · Capsule | Hydrochlorothiazide | United States | Marketed | 1996 |
| MIRCETTE0.15MG,N/A; 0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Desogestrel, N/a, Ethinyl estradiol | United States | Not marketed | 1998 |
| NASAREL0.029mg/spray · Spray, metered | Flunisolide | United States | Not marketed | 1995 |
| NOR-QD0.35mg · Tablet | Norethindrone | United States | Marketed | 1973 |
| NORDETTE-210.03mg; 0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 1982 |
| NORDETTE-280.03MG; 0.15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 1982 |
| PREVEN EMERGENCY CONTRACEPTIVE KIT0.05mg; 0.25mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 1998 |
| PROAIR DIGIHALER0.09mg base/inh · Powder, metered | Salbutamol | United States | Not marketed | 2015 |
| PROAIR HFA0.09mg base/inh · Aerosol, metered | Salbutamol | United States | Marketed | 2004 |
| PROAIR RESPICLICK0.09mg base/inh · Powder, metered | Salbutamol | United States | Marketed | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 38 | 38 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.